PTC Therapeutics Inc PTCT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:11 PM EDT
48.85quote price arrow down-0.30 (-0.62%)
Volume
98,795
52 week range
25.01 - 55.58
Loading...
  • Open49.15
  • Day High50.41
  • Day Low48.62
  • Prev Close49.16
  • 52 Week High55.58
  • 52 Week High Date09/20/22
  • 52 Week Low25.01
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap3.495B
  • Shares Out71.54M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change22.77

KEY STATS

  • Open49.15
  • Day High50.41
  • Day Low48.62
  • Prev Close49.16
  • 52 Week High55.58
  • 52 Week High Date09/20/22
  • 52 Week Low25.01
  • 52 Week Low Date06/16/22
  • Market Cap3.495B
  • Shares Out71.54M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change22.77

RATIOS/PROFITABILITY

  • EPS (TTM)-7.83
  • P/E (TTM)-6.24
  • Fwd P/E (NTM)-9.53
  • EBITDA (TTM)-265.635M
  • ROE (TTM)-7,740.12%
  • Revenue (TTM)618.23M
  • Gross Margin (TTM)94.24%
  • Net Margin (TTM)-89.89%
  • Debt To Equity (MRQ)-662.69%

EVENTS

  • Earnings Date10/26/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PTC Therapeutics Inc

 

Profile

MORE
PTC Therapeutics, Inc. is a science-driven global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company's portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new...
Michael Schmertzler
Independent Chairman of the Board
Stuart Peltz Ph.D.
Chief Executive Officer, Director
Matthew Klein M.D.
Chief Operating Officer
Neil Almstead Ph.D.
Chief Technical Operations Officer
Emily Hill
Chief Financial Officer
Mark Boulding
Executive Vice President, Chief Legal Officer
Address
100 Corporate Ct
South Plainfield, NJ
07080-2400
United States

Top Peers

SYMBOLLASTCHG%CHG
GLPG
Galapagos NV
42.55-1.00-2.29%
NTRA
Natera Inc
42.87-0.77-1.76%
ACAD
ACADIA Pharmaceuticals Inc
16.67-0.08-0.48%
ABCL
Abcellera Biologics Inc
9.38+0.19+2.01%
DNA
Ginkgo Bioworks
2.75-0.04-1.61%